sameAs
Essential role of the coxsackie- and adenovirus receptor (CAR) in development of the lymphatic system in miceIsolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysisFGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complexMultiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradationVEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sproutsVEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brainLymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factorBinding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in miceEffective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerizationVascular endothelial growth factor B, a novel growth factor for endothelial cellsCo-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell linesVascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contactsCCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activationCongenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinaseFOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesisPlasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-DVascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cellsNovel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiationReceptor tyrosine kinase-mediated angiogenesisMouse models for studying angiogenesis and lymphangiogenesis in cancerA dural lymphatic vascular system that drains brain interstitial fluid and macromoleculesAngiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubesIntravital imaging of intestinal lacteals unveils lipid drainage through contractilityStructural determinants of growth factor binding and specificity by VEGF receptor 2Structural determinants of vascular endothelial growth factor-D receptor binding and specificityThermodynamic and structural description of allosterically regulated VEGFR-2 dimerizationStructural and mechanistic insights into VEGF receptor 3 ligand binding and activationSignaling via vascular endothelial growth factor receptorsDifferential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent mannerIdentification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migrationBiosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimersVascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veinsLocalization of the fibroblast growth factor receptor-4 gene to chromosome region 5q33-qterA model for gene therapy of human hereditary lymphedemaVascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.
P50
Q21134565-D9596FBC-4A98-42C4-9A4E-D6626467B51AQ24291630-B439B6B6-2474-4DE4-9E5F-C6A72CE64CB5Q24291733-BA2F671A-9E11-4B1D-84FC-7BCA5D9DAB97Q24297701-1C72F711-4D31-4116-ACD1-6B43191DC1A8Q24300714-2EAA2DB1-1993-4083-834B-85DDC52DBFADQ24301346-FB4551AB-3458-4394-A005-BF601289298BQ24302234-393D6430-2901-4C7F-AD90-A8BD77598B8CQ24303927-4234BA5F-A134-4B87-840B-3C45746426A9Q24305315-81052C97-F8FF-42E4-8D02-5F0EE5F302A3Q24307524-88D49427-D78B-49C8-AF3D-3AB241681249Q24311715-48690D47-947B-4297-A6A4-78B4CC024C77Q24312842-4AB8D343-8C8F-444E-AB4D-A4F3EDF08EE5Q24315692-D5912F36-52AF-484C-BE82-EE8D4AF22407Q24321792-5A1D6EB2-966A-4175-872E-857763A584A6Q24323888-D3701C7F-5B14-46D1-BB7B-88A559B450B1Q24337821-B7D246C0-AD44-4419-A345-85161C892A16Q24538742-8942F596-947F-425D-95F0-E197762E0A11Q24641842-F65DA11D-C5CF-477A-B166-7A6DECD4F66AQ24669710-AB15D833-C415-43A6-A61F-195E15B1668CQ24672582-5671E96A-266C-4BD8-8741-E01EFC2B931EQ24679724-5501D064-AF4A-4B32-8F38-8AB693380681Q24685580-4EC4E47F-D640-4BEA-853A-EDD9C8AC6B0BQ27001612-FC429E79-9B69-4120-BBBA-E1A84C952C92Q27003898-655C404F-542C-43E4-8B9B-2AD2D873A2BAQ27308814-6E0F2406-458E-4A01-AAE2-EC768D270BA7Q27316586-7844AF4A-1BA9-4964-AFB5-5D0A33C65C70Q27333083-9EFBECDB-1583-4269-BECF-357C469749E0Q27659686-11A9A98F-76DB-4A52-8751-0E9E1A8A5886Q27666332-1D612EAD-906B-4577-BA24-2FA04ABE530DQ27676493-E9A0AAF8-5018-4938-A783-1BEBF0C704A9Q27679183-09331967-0F4B-4E51-9566-1A297F98A711Q28139029-177DEB4D-FF0F-4F8E-89B9-1847105715A2Q28139948-4CAD2B13-33F1-4E0F-BCD4-091DF562B326Q28144756-2FE84C98-C6C1-4D2E-9548-379A70FB54CDQ28145912-3582B5C0-B2E1-4262-8BB8-E6CB30630952Q28146110-36327750-F1BF-4E4A-A9AC-8DE68936FA62Q28186603-850C7D13-5898-4A7D-AA1E-B33AD7E7E742Q28187230-DABF5959-7950-45E8-B174-75F0DFF3A6E3Q28191040-15AE41EC-BC86-40ED-B378-219D5949378EQ28200101-80672160-DF9E-4B1B-8B16-42A04BF2FD32
P50
description
Finnish research professor (Ac ...... Research Institute (Helsinki)
@en
Fins moleculair bioloog
@nl
finnischer Mediziner
@de
finsk forsker
@da
suomalainen akatemiaprofessori ...... in tutkimusinstituutin johtaja
@fi
name
Kari Alitalo
@af
Kari Alitalo
@an
Kari Alitalo
@ast
Kari Alitalo
@bar
Kari Alitalo
@br
Kari Alitalo
@ca
Kari Alitalo
@co
Kari Alitalo
@cs
Kari Alitalo
@cy
Kari Alitalo
@da
type
label
Kari Alitalo
@af
Kari Alitalo
@an
Kari Alitalo
@ast
Kari Alitalo
@bar
Kari Alitalo
@br
Kari Alitalo
@ca
Kari Alitalo
@co
Kari Alitalo
@cs
Kari Alitalo
@cy
Kari Alitalo
@da
altLabel
Alitalo, K.
@en
Alitalo, Kari K.
@en
Alitalo, Kari Kustaa
@en
Alitalo, Kari
@en
prefLabel
Kari Alitalo
@af
Kari Alitalo
@an
Kari Alitalo
@ast
Kari Alitalo
@bar
Kari Alitalo
@br
Kari Alitalo
@ca
Kari Alitalo
@co
Kari Alitalo
@cs
Kari Alitalo
@cy
Kari Alitalo
@da
P106
P166
P463
P1006
P214
P244
P1006
P1053
J-5013-2014